1. Home
  2. AZTR vs IMTE Comparison

AZTR vs IMTE Comparison

Compare AZTR & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • IMTE
  • Stock Information
  • Founded
  • AZTR 2014
  • IMTE 2008
  • Country
  • AZTR United States
  • IMTE Malaysia
  • Employees
  • AZTR N/A
  • IMTE N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • AZTR Health Care
  • IMTE Consumer Staples
  • Exchange
  • AZTR Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • AZTR 4.2M
  • IMTE 3.8M
  • IPO Year
  • AZTR 2023
  • IMTE N/A
  • Fundamental
  • Price
  • AZTR $0.49
  • IMTE $1.00
  • Analyst Decision
  • AZTR Strong Buy
  • IMTE
  • Analyst Count
  • AZTR 1
  • IMTE 0
  • Target Price
  • AZTR $4.00
  • IMTE N/A
  • AVG Volume (30 Days)
  • AZTR 5.3M
  • IMTE 93.0K
  • Earning Date
  • AZTR 11-14-2025
  • IMTE 09-26-2025
  • Dividend Yield
  • AZTR N/A
  • IMTE N/A
  • EPS Growth
  • AZTR N/A
  • IMTE N/A
  • EPS
  • AZTR N/A
  • IMTE N/A
  • Revenue
  • AZTR N/A
  • IMTE $123,337.00
  • Revenue This Year
  • AZTR N/A
  • IMTE N/A
  • Revenue Next Year
  • AZTR N/A
  • IMTE N/A
  • P/E Ratio
  • AZTR N/A
  • IMTE N/A
  • Revenue Growth
  • AZTR N/A
  • IMTE 4.75
  • 52 Week Low
  • AZTR $0.47
  • IMTE $0.51
  • 52 Week High
  • AZTR $4.33
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 32.75
  • IMTE 47.31
  • Support Level
  • AZTR $0.47
  • IMTE $0.86
  • Resistance Level
  • AZTR $0.62
  • IMTE $1.05
  • Average True Range (ATR)
  • AZTR 0.08
  • IMTE 0.05
  • MACD
  • AZTR -0.02
  • IMTE -0.00
  • Stochastic Oscillator
  • AZTR 3.74
  • IMTE 53.45

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: